Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratner

Showing results (141-150 of 4,048) with videos related to

Pageof 405
Sort By:
Nature Biotechnology|September 12, 2013
Amgen best-seller challenged by genericsMark Ratner
Nature Biotechnology|February 7, 2018
Approval of first tumor gene panel sends shockwaves through labsMark Ratner
Nature Biotechnology|January 11, 2018
FDA to relax grip on at-home genetic tests, but concerns lingerMark Ratner
Nature Biotechnology|December 5, 2019
Patients with porphyria bask in sunlight of FDA approvalMark Ratner
Nature Biotechnology|December 4, 2020
Microbial cocktails raise bar for C. diff. treatmentsMark Ratner
Microorganisms|January 21, 2022
Epigenetic Regulation of Human T-Cell Leukemia Virus Gene ExpressionLee Ratner
Nature Biotechnology|September 7, 2018
FDA approves first single-dose antimalarialMark Ratner
Frontiers in Microbiology|October 18, 2019
Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma TreatmentLee Ratner
Nature Biotechnology|June 10, 2014
First PDE4 inhibitor for psoriasis hits the market but impact is uncertainMark Ratner
New York State Journal of Medicine|March 19, 2010
Pediatric approach to the management of asthma in childhoodB RATNER
Pageof 405

Showing results (141-150 of 4,048) with videos related to

Sort By:
Pageof 405
Nature Biotechnology|September 12, 2013
Amgen best-seller challenged by genericsMark Ratner
Nature Biotechnology|February 7, 2018
Approval of first tumor gene panel sends shockwaves through labsMark Ratner
Nature Biotechnology|January 11, 2018
FDA to relax grip on at-home genetic tests, but concerns lingerMark Ratner
Nature Biotechnology|December 5, 2019
Patients with porphyria bask in sunlight of FDA approvalMark Ratner
Nature Biotechnology|December 4, 2020
Microbial cocktails raise bar for C. diff. treatmentsMark Ratner
Microorganisms|January 21, 2022
Epigenetic Regulation of Human T-Cell Leukemia Virus Gene ExpressionLee Ratner
Nature Biotechnology|September 7, 2018
FDA approves first single-dose antimalarialMark Ratner
Frontiers in Microbiology|October 18, 2019
Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma TreatmentLee Ratner
Nature Biotechnology|June 10, 2014
First PDE4 inhibitor for psoriasis hits the market but impact is uncertainMark Ratner
New York State Journal of Medicine|March 19, 2010
Pediatric approach to the management of asthma in childhoodB RATNER
Pageof 405